Acceptable HbA1c for diabetes is a key measure guiding treatment decisions and long-term health outcomes across the UK. HbA1c — or glycated haemoglobin — reflects average blood glucose over the preceding two to three months, making it far more informative than a single glucose reading. NICE sets clear target ranges depending on diabetes type, treatment regimen, and individual circumstances, but the right HbA1c for you is always personalised. This article explains what the targets mean, what influences them, and how to bring your HbA1c down safely in line with NHS and NICE guidance.
Summary: An acceptable HbA1c for diabetes is typically 48 mmol/mol (6.5%) for most adults, rising to 53 mmol/mol (7.0%) for those on hypoglycaemia-inducing medications, though targets are always individualised by NICE guidance.
- HbA1c measures average blood glucose over the preceding 2–3 months by assessing the proportion of glycated haemoglobin in red blood cells.
- NICE NG28 recommends 48 mmol/mol (6.5%) for type 2 diabetes managed by lifestyle or metformin, and 53 mmol/mol (7.0%) for those on insulin or sulphonylureas.
- For type 1 diabetes, NICE NG17 recommends a target of 48 mmol/mol (6.5%) or lower where achievable without problematic hypoglycaemia.
- Older, frail adults or those with hypoglycaemia unawareness may have a safer, more relaxed target of up to 58–64 mmol/mol (7.5–8.0%).
- HbA1c results can be unreliable in haemoglobinopathies, advanced CKD, or significant anaemia; alternative monitoring such as fructosamine or CGM may be used.
- Lifestyle changes including low-carbohydrate diet, regular physical activity, and structured education programmes are first-line strategies to improve HbA1c.
Table of Contents
Am I eligible for weight loss injections?
Find out whether you might be eligible!
Answer a few quick questions to see whether you may be suitable for prescription weight loss injections (like Wegovy® or Mounjaro®).
- No commitment — just a quick suitability check
- Takes about 1 minute to complete
What Is HbA1c and Why It Matters in Diabetes Management
HbA1c reflects average blood glucose over 2–3 months and is used both to diagnose type 2 diabetes (≥48 mmol/mol) and to monitor ongoing glycaemic control, with persistently elevated levels linked to serious microvascular and macrovascular complications.
HbA1c — formally known as glycated haemoglobin — is a blood test that reflects your average blood glucose levels over the preceding two to three months. When glucose circulates in the bloodstream, it binds to haemoglobin (the protein inside red blood cells that carries oxygen). The higher your blood glucose over time, the greater the proportion of haemoglobin that becomes glycated. Because red blood cells have a lifespan of approximately 120 days, the HbA1c result provides a reliable snapshot of longer-term glucose control, weighted towards the most recent 8–12 weeks, rather than reflecting a single moment in time.
This makes HbA1c one of the most clinically valuable tools in diabetes management. Unlike a fasting glucose test, which can fluctuate significantly depending on recent meals, stress, or illness, HbA1c offers a more stable and reproducible measure. It is used both to diagnose type 2 diabetes and to monitor ongoing glycaemic control in people already living with diabetes.
Diagnostic use of HbA1c — In non-pregnant adults, an HbA1c of 48 mmol/mol (6.5%) or above is diagnostic of type 2 diabetes. In people without symptoms, a second confirmatory test is required; in people with clear symptoms of diabetes, a single result may be sufficient. Importantly, HbA1c should not be used to diagnose diabetes in the following situations:
-
Children and young people
-
Adults with suspected type 1 diabetes
-
During pregnancy
-
Where a condition affecting red blood cell turnover or haemoglobin structure is present (such as haemolytic anaemia or a haemoglobinopathy)
-
Where symptoms have developed rapidly, suggesting acute hyperglycaemia
In these circumstances, plasma glucose testing is required instead.
A result of 42–47 mmol/mol (6.0–6.4%) indicates non-diabetic hyperglycaemia (NDH) — sometimes called prediabetes — and identifies people at increased risk of developing type 2 diabetes. NHS guidance recommends lifestyle intervention and regular monitoring for this group.
Maintaining an acceptable HbA1c is important because persistently elevated blood glucose is associated with serious long-term complications, including:
-
Microvascular damage — affecting the kidneys (nephropathy), eyes (retinopathy), and nerves (neuropathy)
-
Macrovascular disease — increasing the risk of heart attack, stroke, and peripheral arterial disease
Conversely, pursuing excessively low HbA1c targets — particularly in people on insulin or sulphonylureas — can increase the risk of hypoglycaemia, which carries its own significant health risks. It is also important to note that HbA1c does not replace plasma glucose testing for assessing acute hyperglycaemia or suspected diabetic ketoacidosis (DKA). Understanding what constitutes an acceptable HbA1c for diabetes is therefore a careful balance, tailored to the individual.
Relevant guidance: NICE NG28 (Type 2 diabetes in adults: management); NHS.UK HbA1c test.
NICE Guidelines on Target HbA1c Levels for Diabetes
NICE recommends 48 mmol/mol (6.5%) for type 2 diabetes on lifestyle or metformin, rising to 53 mmol/mol (7.0%) when hypoglycaemia-inducing drugs are used; type 1 diabetes targets are also 48 mmol/mol or lower where safely achievable.
The National Institute for Health and Care Excellence (NICE) provides clear, evidence-based guidance on HbA1c targets for people with diabetes in the UK. These targets differ depending on the type of diabetes, the treatment being used, and individual clinical circumstances.
For type 2 diabetes (NICE NG28), the recommended targets are:
-
48 mmol/mol (6.5%) — for adults managed by lifestyle intervention or a single non-hypoglycaemia-inducing drug (such as metformin)
-
53 mmol/mol (7.0%) — for adults on a drug associated with hypoglycaemia risk (such as a sulphonylurea or insulin), or where a more relaxed target is clinically appropriate
If HbA1c rises to 58 mmol/mol (7.5%) or above despite treatment, NICE recommends reviewing and intensifying therapy, which may involve adding a second or third agent, or initiating insulin.
For type 1 diabetes in adults (NICE NG17), NICE recommends a target of 48 mmol/mol (6.5%) or lower where this can be achieved safely without problematic hypoglycaemia. Individual targets should be agreed collaboratively between the patient and their clinical team.
For children and young people with type 1 diabetes (NICE NG18), NICE recommends aiming for an HbA1c of 48 mmol/mol (6.5%) or lower, though this must be balanced against hypoglycaemia risk and quality of life.
It is important to note that NICE targets are aspirational benchmarks, not rigid thresholds. The NHS and NICE both emphasise that HbA1c targets should be agreed on an individual basis, taking into account a person's overall health, preferences, and ability to self-manage.
Monitoring frequency should be tailored to diabetes type and stability:
-
Type 1 diabetes — typically every 3 months, even when targets are met, given the inherent variability of glucose control
-
Type 2 diabetes not at target — every 3–6 months to guide treatment decisions
-
Stable type 2 diabetes at target — every 6–12 months is generally appropriate
Relevant guidance: NICE NG28; NICE NG17; NICE NG18.
Factors That Affect Your Recommended HbA1c Range
Age, frailty, hypoglycaemia risk, pregnancy, cardiovascular disease, and conditions affecting red blood cell turnover all influence the appropriate HbA1c target, which should be agreed individually with a clinician.
Whilst NICE provides population-level targets, the acceptable HbA1c for any individual with diabetes is influenced by a range of clinical and personal factors. Healthcare professionals are trained to consider these carefully when agreeing a personalised target with their patient.
Age and frailty play a significant role. In older adults, particularly those who are frail or have multiple long-term conditions, tighter glycaemic control may offer limited benefit whilst substantially increasing the risk of hypoglycaemia, falls, and hospital admission. In such cases, a more relaxed target — sometimes up to 58–64 mmol/mol (7.5–8.0%) — may be more appropriate and safer.
Hypoglycaemia risk is another critical consideration. Certain medications, particularly insulin and sulphonylureas (such as gliclazide), lower blood glucose in a way that can cause hypoglycaemia if targets are set too ambitiously. People who have experienced severe hypoglycaemia, or who have hypoglycaemia unawareness (where the usual warning symptoms are absent), may require a higher HbA1c target to maintain safety (NICE NG17).
Other factors that may influence your recommended HbA1c range include:
-
Pregnancy — women with pre-existing diabetes are advised to aim for an HbA1c of 48 mmol/mol (6.5%) or lower before conception and as low as safely possible during pregnancy, due to the risks of congenital abnormalities and obstetric complications (NICE NG3)
-
Cardiovascular disease — evidence reviewed within NICE guidance (drawing on large trials including ACCORD, ADVANCE, and VADT) suggests that very intensive glucose lowering in people with established cardiovascular disease may not confer additional benefit and could in some circumstances be harmful; targets should therefore be individualised
-
Renal impairment and other conditions affecting red blood cell turnover — HbA1c results may be unreliable in people with advanced chronic kidney disease (CKD), those receiving dialysis or erythropoietin (EPO) therapy, or those with significant anaemia or haemoglobinopathies (such as sickle cell disease or thalassaemia), as these conditions alter red blood cell lifespan. In such cases, alternative markers such as fructosamine may be used, or continuous glucose monitoring (CGM) and time-in-range metrics may complement or guide management (NICE NG17; NHS.UK)
-
Mental health and self-management capacity — psychological wellbeing, health literacy, and access to support all influence what is realistically achievable
Relevant guidance: NICE NG28; NICE NG17; NICE NG3; NHS.UK HbA1c test.
How to Lower Your HbA1c Safely
Dietary changes, regular physical activity, structured diabetes education, and medication review are the main evidence-based strategies to lower HbA1c; any adjustments should be discussed with a GP or diabetes team to avoid hypoglycaemia.
If your HbA1c is above your agreed target, there are several evidence-based strategies that can help bring it down safely. Importantly, any changes to your management should be discussed with your GP, diabetes nurse, or specialist team — particularly if you are on insulin or other glucose-lowering medications, where adjustments carry a risk of hypoglycaemia.
Dietary changes are one of the most effective ways to improve HbA1c. A diet lower in refined carbohydrates and added sugars can significantly reduce post-meal glucose spikes. NICE NG28 and Diabetes UK evidence-based nutrition guidance support a range of dietary approaches, including:
-
Low-carbohydrate diets — evidence supports their short-to-medium-term effectiveness in type 2 diabetes
-
Mediterranean-style eating — associated with improved glycaemic control and cardiovascular benefit
-
Portion control and regular meal timing — helps to stabilise blood glucose throughout the day
Referral to a structured diabetes education programme — such as the NHS-commissioned DESMOND (for type 2 diabetes), DAFNE (for type 1 diabetes), or X-PERT — can provide practical, evidence-based support for self-management. Details of these programmes are available on the NHS website.
Physical activity is equally important. In line with UK Chief Medical Officers' physical activity guidelines, adults should aim for at least 150 minutes of moderate-intensity aerobic activity (such as brisk walking, cycling, or swimming) or 75 minutes of vigorous-intensity activity per week, alongside muscle-strengthening activities on two or more days per week. Reducing prolonged periods of sitting is also recommended. Both aerobic exercise and resistance training improve insulin sensitivity and can meaningfully reduce HbA1c.
Medication review may also be warranted. If lifestyle measures alone are insufficient, your GP may consider adding or adjusting glucose-lowering therapy. For people with type 2 diabetes, newer agents such as SGLT-2 inhibitors (e.g., empagliflozin, dapagliflozin) and GLP-1 receptor agonists (e.g., semaglutide) have demonstrated significant HbA1c reductions alongside cardiovascular and renal benefits, and are recommended within NICE pathways for appropriate patients (NICE NG28 and relevant Technology Appraisals). These medicines are not indicated for type 1 diabetes. If you are prescribed any new medication, please read the patient information leaflet supplied with it. Suspected side effects from any medicine should be reported to the MHRA Yellow Card Scheme (available at yellowcard.mhra.gov.uk).
Experiencing these side effects? Our pharmacists can help you navigate them →
Urgent red flags — seek immediate medical advice if you experience:
-
Symptoms that may suggest diabetic ketoacidosis (DKA): nausea or vomiting, abdominal pain, rapid or deep breathing, drowsiness, or ketones detected on a home test — call 999 or go to A&E immediately
-
Very high blood glucose with signs of dehydration — seek same-day urgent medical advice
-
Recurrent or severe hypoglycaemia — contact your GP or diabetes team promptly; do not adjust insulin doses without professional guidance
When to contact your GP or diabetes team: You should seek a review if your HbA1c has risen above your agreed target at your last check, if you are experiencing frequent hypoglycaemia, or if you have concerns about your current treatment.
Relevant guidance: NICE NG28; Diabetes UK evidence-based nutrition guidelines; UK Chief Medical Officers' Physical Activity Guidelines; NHS DESMOND, DAFNE, and X-PERT programme pages; MHRA/EMC SmPCs for SGLT-2 inhibitors and GLP-1 receptor agonists.
Frequently Asked Questions
What is a normal or acceptable HbA1c level for someone with type 2 diabetes in the UK?
For most adults with type 2 diabetes managed by lifestyle changes or metformin, NICE recommends an HbA1c target of 48 mmol/mol (6.5%). If you are taking a medication that can cause hypoglycaemia, such as a sulphonylurea or insulin, a slightly higher target of 53 mmol/mol (7.0%) is generally recommended.
How often should HbA1c be checked in people with diabetes?
People with type 1 diabetes should have their HbA1c checked approximately every three months. For type 2 diabetes, testing every three to six months is recommended if targets are not met, reducing to every six to twelve months once stable and at target.
Can HbA1c results ever be unreliable?
Yes — HbA1c results can be unreliable in people with haemoglobinopathies (such as sickle cell disease or thalassaemia), significant anaemia, advanced chronic kidney disease, or those receiving dialysis or erythropoietin therapy, as these conditions alter red blood cell lifespan. In such cases, alternative tests such as fructosamine or continuous glucose monitoring may be used.
The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.
The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.
Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
